News

Bridging the Gap Between Medical AI Research and Real-World Clinical Impact

Artificial Intelligence (AI) has tremendous potential to advance healthcare and improve the lives of everyone. But successful clinical translation requires evaluating the performance of AI models on large and diverse real-world datasets.

News

Boston Needs its Own Cancer Center. Dana-Farber and Beth Israel Deaconess Medical Center Will Create it

Our collaboration’s shared vision and commitment will allow researchers and clinicians to continue to work together to discover and provide new approaches to cancer care.

Symposium

ESMO Congress 2023 Research Highlights

Lung, kidney, and neuroendocrine tumor cancer studies led by Dana-Farber presented at ESMO Congress 2023.

News

Trials for Hodgkin Lymphoma Patients Who Relapse on Immunotherapies

Classic Hodgkin lymphoma (cHL) is a chemotherapy-sensitive tumor and chemotherapy has been the backbone of treatment for both untreated and relapsed/refractory (R/R) disease

News

Shorter Course of Radiation Therapy is Safe for Patients with Early-Stage Breast Cancer who Have Undergone Mastectomy and Reconstruction

Cancer-related and physical outcomes were similar between longer and shorter regimens, but patients reported less burden on life and finances with shorter treatment regimen.

News

Ultrasensitive Blood Test Detects ‘Pan-Cancer’ Biomarker

Diagnostic tools for timely, accurate and inexpensive early cancer detection that can assess risk or monitor response to treatment could help patients get the care they need faster and improve existing care strategies.